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HemozoinFew studies have investigated the pathophysiologic mechanisms responsible for what seems to be a possible
interaction between Plasmodium falciparum, the causative agent of malaria, and HIV-1 in dually infected
patients. It has been shown that Plasmodium parasites detoxify heme molecules into a pigment called
hemozoin (HZ), which can signiﬁcantly modulate the immune system. The primary objective of this study
was to determine whether exposure of human primary monocyte-derived macrophages (MDMs) to the
malaria pigment inﬂuences the process of HIV-1 infection. We report here that HIV-1 replication is
signiﬁcantly diminished in HZ-loaded MDMs. The HZ-mediated reduction in virus replication is due to a
block at a step in the virus life cycle occurring between the completion of full-length reverse transcripts and
integration of viral DNA within the host chromosome. Understanding the pathological mechanisms involved
in P. falciparum and HIV-1 co-infection is of high importance because of possible therapeutic ramiﬁcations.
© 2009 Elsevier Inc. All rights reserved.Introduction
Malaria and acquired immune deﬁciency syndrome (AIDS) are
responsible for major health problems in many regions of the world.
By the end of 2007, an estimated 33.2 million people were living with
human immunodeﬁciency virus type-1 (HIV-1), of whom 2.5 million
were newly infected (WHO, 2007). Plasmodium falciparum, the
infectious agent of malaria, is thought to be responsible for 1.5–2.7
million deaths and 350–500 million acute illnesses annually (Breman,
2001; WHO, 2002). Together, both infectious diseases cause more
than 4 million deaths a year. To a substantial extent P. falciparum and
HIV-1 infections are concentrated in the same geographical regions.
The resulting co-infection and interactions between the two patho-
gens have major public health implications. Studies based on P.
falciparum and HIV-1 co-infection, whether clinical or laboratory,
have been inconclusive to fully understand the exact mechanisms by
which those two microorganisms interact.
HIV-1 is a single-stranded RNA retrovirus which can infect a
number of different target cells, including CD4-expressing macro-
phages and T-helper lymphocytes. The infection begins with the
interaction of the virus-encoded external glycoprotein 120 (i.e.,virologie Humaine, Centre de
r de l'Université Laval, 2705
+1 418 654 2212.
M.J. Tremblay).
ll rights reserved.gp120) with the host's cell surface CD4 molecule and chemokine
coreceptor CCR5 or CXCR4. As the virus enters the cell, the conversion
of the viral genomic RNA into double-stranded DNA is achieved by the
virus-produced reverse transcriptase. Once reverse transcription has
occurred, the pre-integration complex, promoted by HIV-1 DNA Flap
formation, undergoes uncoating at the nuclear pore (Arhel et al.,
2007). Uncoating is an essential step in the viral replication cycle and
the exact mechanism(s) involved remains controversial to this day.
Thereafter, the viral DNA migrates to and enters the host cell nucleus
and becomes integrated into the cell DNA with the help of the virus
integrase. The provirus can then remain latent or be active, generating
new virions emerging from the host cell membrane.
At the end of the 19th century, malaria was diagnosed by the
presence of a dark pigment in various organs of patients (Hempel-
mann, 2007). Later, Brown (1911) began a long and continuing debate
by suggesting that those pigments were involved in various
physiopathological aspects of malaria. The parasite multiplies by
ingesting hemoglobin found in the host's cytosol. This process leads to
hemoglobin degradation as a source of amino acids and the formation
of free heme, which is a byproduct known to be highly toxic to the
parasite. The essential ﬁrst step in detoxiﬁcation of heme is its
incorporation into an intracellular crystal called malarial pigment or
hemozoin (HZ) (Pisciotta and Sullivan, 2008). Results from in vitro
and in vivo studies indicate that, after the parasite's schizont rupture
in red blood cells, crude HZ and a variety of attached components of
parasite and host origin (e.g., lipids and phospholipids, lipid
derivatives and proteins) are avidly taken up by phagocytes (i.e.,
Fig. 1. sHZ is biologically active. Murine J774 cells (1.25×104) were initially treated with
PMAandnext either left untreated (Ctrl) or treatedwith sHZ (10 μg/ml). Finally, half of the
samples were incubated with IFN-γ (100 U/ml). Nitric oxide production was assessed
through the use of the Griess reagent (A). Results are a schematic representation of data
from triplicate samples±SEM of three independent experiments. Human primary MDMs
(5×104) were either left untreated (Ctrl) or treatedwith sHZ (10 μg/ml) for the indicated
time periods. Levels of IL-1βwere assessed by using a commercial test (B). Measurements
were done on two distinct donors.
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(Arese and Schwarzer, 1997; Coban et al., 2002). Interestingly, it has
been demonstrated that HZ can persist in macrophages of infected
individuals for several months (Millington et al., 2007; Pisciotta and
Sullivan, 2008; Schwarzer et al., 1998).
Blood-circulating monocytes when located in tissues can differ-
entiate into macrophages and dendritic cells in response to danger
stimuli (Mantovani, Sica, and Locati, 2005). Due to their migratory
behavior and their key functions in immune system responses, it is
not surprising that cells of the monocyte–macrophage lineage are the
preferential targets of both P. falciparum and HIV-1 (Arﬁ et al., 2008;
McGilvray et al., 2000). Like with P. falciparum, macrophages have
been described as being important in HIV-1 infection by contributing
to the pathogenesis of the disease throughout the course of infection
(Kedzierska and Crowe, 2002). Indeed, tissue macrophages can be
infected with HIV-1 under both in vitro and in vivo conditions.
Following infection with HIV-1, macrophages are resistant to the
virus-mediated cytopathic effects and serve throughout the course of
infection as long-term stable viral reservoirs capable of disseminating
the virus to tissues.
Some of the diseases seen in the setting of P. falciparum and HIV-1
co-infection have been well described in a recent review paper
(Skinner-Adams et al., 2008). Although it is now appreciated that
malaria and HIV-1 are causing bidirectional and synergistic interac-
tions, there is still a paucity of data with regard to the mechanism(s)
by which each pathogen impacts the other. Therefore, given the
overlapping geographic distribution of both diseases and the urgent
need for basic research in this area, the aims of this study were
articulated as follows: (1) investigating whether exposure to the
puriﬁed malaria pigment HZ inﬂuences HIV-1 replication in human
primary macrophages and, if so, (2) understanding the mechanism(s)
by which HZ can modulate the process of virus infection.
Results
Chemical synthesis and phagocytosis of malaria pigments
Synthetic HZ (sHZ), when prepared in vitro under acidic condi-
tions, is spectroscopically identical and morphologically similar to the
native HZ isolated directly from P. falciparum cultures (Taramelli et al.,
2001). Moreover, both synthetic and native HZ undergo the same
process when internalized by phagocytes (Noland, Briones, and
Sullivan, 2003; Olliaro et al., 2000; Pagola et al., 2000). Consequently,
most of our experiments were performed with synthetic HZ. The
biological activity of our sHZ stock was authenticated by measure-
ment of nitric oxide levels following a brief exposure of the murine
macrophage cell line J774 to IFN-γ as described previously (Bergeron
and Olivier, 2006; Jaramillo et al., 2003). The sHZ preparation was
found to be biologically active since a higher production of nitric oxide
was seen in sHZ-treated cells upon the addition of IFN-γ (Fig. 1A).
Moreover, sHZ was found to mediate a signiﬁcant secretion of IL-1β in
human primary MDMs (Fig. 1B), which conﬁrms that the studied sHZ
preparation is biologically active.
The next set of experiments was aimed at evaluating the ability of
MDMs to engulf sHZ. To this end, cells were exposed to sHZ and
phagocytosis of themalaria pigment wasmonitored during 24 h using
a spinning disk confocal microscope. Acquisition was saved every
4 min and representative pictures were chosen. As shown in Fig. 2,
malaria pigments were phagocytosed efﬁciently by MDMs. Further-
more, a single cell can phagocyte several crystals of malaria pigments,
but the number of phagosomes containing sHZ was restricted (i.e., a
maximum of one to three per individual cell). Phagocytosis was not
only observed during the chosen time-range but also during the entire
recording (data not shown). For that reason, treatment of MDMs with
sHZ was made 24 h prior to HIV-1 infection, unless otherwise
speciﬁed.sHZ inhibits HIV-1 replication in MDMs in a dose-dependent manner
regardless of the viral preparations
Next, we utilized sHZ to measure its putative impact on HIV-1
infection in MDMs. First, MDMs were initially treated for 24 h with
increasing concentrations of sHZ (ranging from 0.1 to 25 μg/ml) and
infected with fully infectious R5-tropic virus (i.e., NL4-3Balenv) for 16
days. Results illustrated in Fig. 3A indicate that HIV-1 production in
MDMs is signiﬁcantly reduced in a dose-dependent fashion by
concentrations of sHZ starting at 5 μg/ml. Importantly, cell viability
was not affected by doses of sHZ that can diminish virus replication as
monitored by the ﬂuorescent cytotoxic MTS assay (Fig. 3B) and
annexin V/7AA-D test (data not shown). To eliminate the possibility
that sHZ could affect the phagocytic capability of MDMs, which could
in turn reduce virus uptake, we estimated zymosan phagocytosis. As
shown in Fig. 3C, sHZ is not altering the phagocytic capacity of MDMs.
Cells were then infected with four different R5-tropic virus
preparations, i.e., fully infectious NL4-3Balenv and NL4-3Bal-HSA as
well as single-cycle reporter virus pseudotyped either with JR-FL
(NL4-3Luc+Env−R+/JR-FL) or VSV-G envelope (NL4-3Luc+Env−R+/
VSV-G). It should be noted that, unlike most of the previous reporter
constructs, the NL4-3Bal-HSA molecular construct leads to the
production of fully competent viruses with no deletions in env, vpr
or nef. Moreover, NL4-3Bal-HSA virus codes for a cell surface reporter
molecule, namely, the murine heat-stable antigen (HSA) CD24, which
permits to quantify the percentage of cells productively infected with
HIV-1 (Imbeault et al., 2009). Virus infection was estimated at 6 days
post-infection for all virus stocks tested by measuring either the p24
content, luciferase activity or percentage of HSA-expressing cells.
Fig. 2. Phagocytosis of sHZ by MDMs. Cells were ﬁrst plated at a concentration of 1×105 cells per well and treated next with a DiD cell-labeling solution. Thereafter, MDMs were
exposed to sHZ (10 μg/ml). Images were obtained using time lapse imaging, performed on a WAVE/FX spinning disk confocal microscope. Similar experimental conditions were
maintained for all images throughout a 24 h recording (i.e., exposure time every 4 min, 60×magniﬁcation and laser and intensity levels). Representative images of sHZ phagocytosis
by MDMs selected here illustrate the ﬂuorescence imaging of stained cells (A) and the differential interference contrast images of the same cells (B). Digital images were processed
with ImageJ (version1.36b) and Velocity (version 4.2.1, Improvision).
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infection of MDMs with NL4-3Balenv was inhibited in a dose-
dependent fashion by sHZ (e.g., percentages of inhibition of 21±4.1
at 0.1 μg/ml, 29±5.2 at 1 μg/ml and 46±4.6 at 10 μg/ml) (Fig. 4A).
Infection of MDMs in the absence of sHZ led to a virus production of
115±24.5 ng/ml of p24. Infection with HIV-1 reporter virus
pseudotyped with JR-FL envelope was also reduced in a dose-
dependent manner by sHZ (e.g., percentages of inhibition of 26±
2.7 at 0.1 μg/ml, 45±5.8 at 1 μg/ml and 85±7.1 at 10 μg/ml)
(Fig. 4B). Luciferase activity detected in untreated control cells was
equal to 64±11.1 relative light units (RLU). Similar observations
were made when we used reporter virus that can enter target cells
through endocytosis and independently of CD4 and chemokine
coreceptor (i.e., NL4-3Luc+Env−R+/VSV-G pseudotypes) (Fig. 4C).
However, as expected, reporter gene activity detected in untreated
and treated MDMs was more important than when infection was
performed with JR-FL pseudotypes (e.g., 2310±1557 RLU in
untreated control cells). Again, a signiﬁcant sHZ-mediated reduction
in virus production (about 43% at 25 μg/ml) was seen when MDMs
were inoculated with fully competent HIV-1 particles that can
express, in addition to all virus proteins, the murine cell surface
molecule HSA (Fig. 4D).
The physiological signiﬁcance of our ﬁndings was addressed by
comparing side-by-side our sHZ preparation with natural HZ directly
isolated from P. falciparum cultures (PfHZ). Details of the procedure
for the isolation of natural malaria pigments have already been
described previously (Pisciotta et al., 2007). As illustrated in Fig. 5,
infection of MDMs with JR-FL pseudotypes was inhibited at
comparable signiﬁcant levels in presence of sHZ and PfHZ (i.e.,
percentages of inhibition of 73 and 78, respectively).
sHZ-loaded MDMs are sensitive to HIV-1 infection
In view of the results shown above, we next wanted to deﬁne
whether the sHZ-dependent diminution of HIV-1 gene expression is
only occurring in cells loaded with malaria pigments. Accordingly, we
performed confocal microscopy analyses using MDMs pretreated for
24 h with increasing concentrations of sHZ and then infected with
fully competent HSA-encoding virus. Data from Fig. 6A demonstrated
that the physical presence of sHZ in the target cell does not prevent
HIV-1 infection and virus gene expression. Indeed, through the use of
classical confocal microscopy (upper panels) and differential inter-ference contrast microscopy (bottom panels), we were able to
monitor at a single-cell level the frequency of sHZ-loaded MDMs
and cells productively infected with HIV-1. Furthermore, at the
highest concentrations tested (i.e., 10 and 25 μg/ml) more then 80% of
the general population of MDMs accumulate sHZ in their cytoplasm.
Although it is clear that a single cell can harbor sHZ and allow HIV-1
production, virus gene expressionwas rarely seen inMDMs ﬁlled with
high quantities of sHZ. Indeed, an in-depth analysis of several hundred
cells indicated that when an estimated 75% of the cell's cytoplasmwas
ﬁlled with sHZ those MDMs were weakly infected or not at all (see
bottom panels and data not shown). Quantiﬁcation of the image
analysis corroborates that sHZ is abrogating virus production in
MDMs (Fig. 6B).
sHZ inhibits an early intracellular event in HIV-1 life cycle
In a previous work aimed at studying HIV-1 dynamics in cells
isolated from HIV-1-infected patients, the duration of the virus
replicative cycle in vivo was evaluated at 1.2 days on average
(Perelson et al., 1996). Moreover, the average HIV-1 generation time
from release of a virion until it infects another cell and causes the
release of a new generation of viral particles was estimated to be 2.6
days (Perelson et al., 1996). Consequently, to identify which step(s) in
the virus life cycle is affected by the malaria pigment, MDMs were
infected with JR-FL pseudotypes and treated at different time points
with two concentrations of sHZ. When 5 μg/ml of sHZ was added at 0
and 4 h post-infection, an important decrease in virus-encoded
reporter gene activity was measured (i.e., percentages of inhibition of
48.2% and 38.9%, respectively) (Fig. 7). A similar diminution was seen
when 10 μg/ml of sHZ was added at 0, 4 and 24 h post-infection (i.e.,
percentages of inhibition of 58.3, 45.8 and 38.7, respectively).
Moreover, a more signiﬁcant reduction in virus gene expression was
detected when sHZ was added 24 h before HIV-1 infection (i.e.,
percentages of inhibition of 70.6 with 5 μg/ml and 79.4 with 10 μg/
ml). Importantly, the addition of sHZ at 48 and 72 h post-infection had
no effect on HIV-1 expression, thus suggesting that malaria pigments
are modulating an early event in the HIV-1 life cycle.
Next, we attempted to identify more precisely how sHZ can limit
HIV-1 replication in MDMs. We evaluated whether ingestion of sHZ
could reduce entry of virions within the studied target cells. To this
end, MDMs were infected for 1 h either with fully infectious NL4-
3Balenv or JR-FL pseudotypes, trypsinized and extensively washed to
Fig. 4. sHZ inhibits HIV-1 replication inMDMs regardless of virus preparation.MDMswere
either left untreated or treated with increasing concentrations of sHZ (0.1–25 μg/ml) for
24 h. Next, cells were infected for 6 days with fully infectious virus (i.e., NL4-3Balenv) (A),
single-cycle HIV-1 reporter virus pseudotyped eitherwith JR-FL (B) or VSV-G envelope (C)
and fully competent virus coding for the cell surface reporter murine HSA molecule (D).
The extent of virus infection was measured by estimating p24 contents (A), luciferase
activity (B and C) or percentage of HSA-positive cells by ﬂow cytometry (D). Data shown
correspond to percentages of inhibition ofHIV-1 infection. Those resultswere calculatedby
comparing MDMs which have been treated with sHZ and later infected versus untreated
MDMs only infectedwithHIV-1. Results aremean±SEMof data from triplicate samples of
several independent experiments (i.e., 2, 5, 6 and 4, respectively, to the illustrated order).
Statistical analysis was performed on the results from all experiments. Asterisks denote
statistically signiﬁcant data (⁎, Pb0.05; ⁎⁎, Pb 0.01).
Fig. 3. sHZ inhibits HIV-1 replication in MDMs in a dose-dependent manner without
affecting cell viability and phagocytic activity. MDMswere either left untreated (ctrl) or
treated with increasing concentrations of sHZ (0.1–25 μg/ml) for 24 h. Next, cells were
infected for 16 days with fully infectious virus (i.e., NL4-3Balenv) (A). The extent of
virus infection was measured by estimating p24 contents every 3 days. At 16 days post-
infection (dpi), cell viability was measured using MTS assay as described in Materials
and methods (B). In some instances, MDMs were not infected and utilized as a positive
control for cell viability (called mock). In some experiments, cells were pretreated with
sHZ (10 μg/ml) and next incubated with ﬂuorescently labeled zymosan to estimate the
phagocytic potency of MDMs. Flow cytometry was used to deﬁne the percentage of
zymosan-positive cells and mean ﬂuorescence intensity (MFI). Results are a schematic
representation of data from triplicate samples±SEM of three independent experi-
ments. Statistical analysis was performed on the results from all experiments. Asterisks
denote statistically signiﬁcant data (⁎⁎, Pb 0.01).
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p24 concentrations were quantiﬁed. No signiﬁcant changes in virus
internalization were noted when MDMs were treated with two
different concentrations of sHZ before HIV-1 infection (Fig. 8).
Knowingmalaria pigments had no impact on HIV-1 entry, we then
monitored HIV-1 reverse transcription by quantifying various forms
of virus reverse transcripts at different time points (i.e., 0, 4, 8, 24 and
48 h post-infection) in MDMs pretreated with 10 μg/ml of sHZ.
Results obtained by real-time PCR assays indicate that the number of
initiated and completed viral DNA copies is not reduced upon sHZ
Fig. 5. HIV-1 replication is similarly reduced by sHZ and PfHZ. MDMs were either left
untreated (Ctrl) or treated with sHZ and PfHZ (10 μg/ml) for 24 h. Thereafter, cells were
infected for 6 days with single-cycle HIV-1 reporter virus pseudotyped with JR-FL
envelope. Finally, luciferase activity was measured using a luminometer and converted
in percentages of inhibition as described in Fig. 3. Statistical analysis was performed on
the results. Asterisks denote statistically signiﬁcant data (⁎⁎, Pb 0.01).
Fig. 7. sHZ inhibits an early event in HIV-1 life cycle. MDMswere either left untreated or
treated with the indicated concentrations of sHZ at different time points after (i.e., 0, 4,
24, 48 and 72 h) and 24 h before infection (PRE) for 6 days with single-cycle HIV-1
reporter virus pseudotyped with JR-FL envelope. Luciferase activity was measured
using a luminometer. Virus infection is illustrated in percentages of inhibition as
described in Fig. 3. Results are mean±SEM of data from triplicate samples of four
independent experiments. Statistical analysis was performed on the results from all
experiments. Asterisks denote statistically signiﬁcant data (⁎, Pb 0.05; ⁎⁎, Pb 0.01).
60 J. Diou et al. / Virology 395 (2009) 56–66treatment (data not shown and Fig. 9), therefore suggesting that the
reverse transcription process is not a target of malaria pigments.
Changes seen between samples in the copy numbers of HIV-1 reverse
transcripts is most likely due to the intrinsic donor-to-donor
variations. In such experiments, free heme was used as a positive
control (data not shown) based on the previous demonstration thatFig. 6. HIV-1 replication can occur in sHZ-loadedMDMs. Cells were either left untreated or treated with increasing concentrations of sHZ (1–25 μg/ml) for 24 h. Thereafter, cells were
infected for 6 dayswith fully infectious reporter virus coding for cell surfacemurineHSA. Cellsweremounted andprocessed for confocalmicroscopy analysis.MDMswere stainedwith
Alexa Fluor 488-labelled phalloidin to reveal the F-actin cytoskeleton (red) and a conjugated antibody speciﬁc for HSA to reveal cells productively infectedwithHIV-1 (green) (A). Red
arrows on the bottom panel illustrate examples of cells with at least 75% of sHZ accumulation in their cytoplasm. Micrographs are representative of three independent donors. The
extent of productive virus infectionwasmeasured by estimating the percentage of HSA-positive cells by ﬂow cytometry (B). Results aremean±SEMof data from triplicate samples of
four independent experiments. Statistical analysis was performed on the results from all experiments. Asterisks denote statistically signiﬁcant data (⁎⁎, Pb 0.01).
Fig. 8. Virus entry is not affected by sHZ. MDMs were either left untreated (Ctrl) or
treatedwith sHZ (i.e., 5 and 10 μg/ml) for 24 h. Next, cells were incubated for 1 h at 37 °C
with fully competent NL4-3Balenv (A) and single-cycle HIV-1 reporter virus pseudo-
typed with JR-FL envelope (B). The virus–cell mixture was extensively washed and
treated with trypsin (5 min at 37 °C), washed again and ﬁnally lysed. The viral content
was measured using the p24 assay. In some instances, MDMs were put in contact with
HIV-1 for less than a minute (called Mock). Results are mean±SEM of data from
triplicate samples of ﬁve independent experiments. Statistical analysis was performed
on the results from all experiments and no signiﬁcant variations were measured.
Fig. 9. sHZ has no impact on HIV-1 reverse transcription. MDMs were either left
untreated (Ctrl) or treated with 10 μg/ml of sHZ for 24 h. Thereafter, cells were
maintained in the absence of HIV-1 or infected for the indicated time periods (i.e., 0, 4, 8,
24 and 48 h) with fully competent NL4-3Balenv. Finally, for each speciﬁc time point,
genomic DNA was extracted to quantify full-length HIV-1 reverse transcripts. Results
shown are mean±SEM of data from duplicate samples from a single donor and are
representative of three different donors (A). Results depicted represent mean±SEM of
the ratio of sHZ-treated cells over untreated cells from the three different donors (B).
Fig. 10. sHZ is affecting viral integration in MDMs. MDMs were either left untreated
(Ctrl) or treatedwith 5 μg/ml of sHZ for 24 h. Next, cells were infected for 48 hwith fully
competent NL4-3Balenv. Genomic DNA was extracted and quantiﬁcation of integration
events was achieved using a real-time PCR protocol described inMaterials andmethods.
Results aremean±SEMof data from triplicate samples of six independent experiments.
Asterisks denote statistically signiﬁcant data (⁎⁎⁎, Pb 0.001).
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transcriptase activity (Staudinger et al., 1996).
Thereafter, integrated viral DNA copies were estimated also by
real-time PCR in MDMs pretreated with sHZ and infected with fully
infectious HIV-1 particles (i.e., NL4-3Balenv). The integration process
was signiﬁcantly reduced by a pretreatment with sHZ (Fig. 10).
Similar observations were made when using NL4-3Bal-HSA and JR-FL
pseudotypes (data not shown).
Discussion
Little is known about the possible impact of malaria pigments on
HIV-1 replication in human primary cells known to harbor the virus
under natural conditions. Indeed, most studies are clinical and relate to
HZ and its inﬂuence on mother-to-child transmission of HIV-1
(Chaisavaneeyakorn et al., 2003; Moore et al., 2004; Moormann et al.,
1999). We chose to focus our studies on malaria pigments because the
presence of HZ inmonocytes andneutrophils was described as amarker
for disease severity (Huy et al., 2006). Furthermore, pigmented
neutrophils were associatedwith cerebralmalaria and death in children
with severe malaria (Lyke et al., 2003). Several studies have shown
signiﬁcant functional impairments in human cells caused by themalaria
pigment such as a defective generation of the oxidative burst, an
impairedphagocytic competence anda reducedproteinkinaseC activity
(Millington et al., 2007; Pisciotta and Sullivan, 2008; Schwarzer et al.,
1998). As a result, the more important HIV-1 load observed in some
Plasmodium-infected individuals (Kublin et al., 2005) may be the result
of the incapacity of the immune system to appropriately control other
microbial infections possibly due to HZ-mediated disorders of innate
immune cells. As so, we were interested in studying the impact ofmalaria pigments on the HIV-1 life cycle in human primary MDMs.
Because the majority of studies aimed at deciphering the possible HZ-
modulated immune functional deﬁciencies were using transformed or
immortalized cell lines, we ﬁrstly investigated whether co-infection
results obtained with those cell lines were representative of data
obtained with human primary cells such as MDMs. Preliminary studies
showed an increase of HIV-1 infection in the human acute monocytic
leukemia cell line, THP-1, upon a pretreatment with sHZ (data not
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sHZ was found to exert an opposite effect on HIV-1 replication. The
explanation for this discrepancy is currently unknown and deserves to
be more fully addressed.
Here we conﬁrm that MDMs rapidly ingest large amounts of sHZ
and demonstrate for the ﬁrst time that the malaria pigment causes a
reduction in HIV-1 replication in this cell type. It has been
demonstrated that malaria pigment can induce a severe impairment
of phagocytic cells functions. Therefore, we used a red-ﬂuorescent dye
to stain acidic compartments in live cells in order to appreciate
interactions between sHZ and MDMs in an attempt to shed light on
how sHZ can modulate virus replication. At a given point, fully
functional cellular lysosomal compartments were interacting with
sHZ-fed phagosomes but were incapable to induce their degradation
(data not shown). Taking into account that last result and the
possibility that the only presence of sHZ could preclude the uptake of
HIV-1, we tested the ability of MDMs to phagocyte ﬂuorescently
labeled zymosan particles. No signiﬁcant differences were noticed as
compared to the untreated control cells.
The entry process is the ﬁrst critical step in the HIV-1 replicative
cycle. It has been reported that HIV-1 enters macrophages by
macropinocytosis and viral receptor-mediated fusion (Maréchal et
al., 2001; Yi et al., 2008). Similar amounts of internalized virions were
detected in both untreated and sHZ-loaded MDMs, therefore
indicating that the reduction of viral infection observed in sHZ-loaded
MDMs is not caused by a decrease in HIV-1 entry.
Following entry in the cytosol, incoming subviral complexes
interact with the actin cytoskeleton and the microtubule network to
reach the nuclear pore (Arhel et al., 2006a; Campbell, Nunez, and
Hope, 2004; McDonald et al., 2002). Any factor interfering with the
actin and/or the microtubule network may affect the transit of the
reverse transcription complex (RTC) to the nucleus and consequently
the completion of the virus replicative cycle. The impact of sHZ
engulfment on actin and microtubule networks remains unknown.
However, based on data reported by Moller and colleagues (2002)
who showed that uptake of indigestible particles induces cellular
stiffness, impairs phagocytic activity and delays intracellular transport
in macrophages, it can be proposed that sHZ can interfere with the
integrity of the cytoskeletal network. Although we cannot exclude
that the intracellular transport is affected by sHZ, data from
experiments with zymosan revealed that sHZ does not affect
phagocytosis. These results suggest that the cytoskeletal network
remains functional in sHZ-loadedMDMs and can thus be used by HIV-
1 to move toward the nucleus.
It is now accepted that reverse transcription (RT) is initiated
within an integral capsid core during the transit toward the nucleus
(Arhel et al., 2007) and completed at the nuclear pore. Interestingly, it
has been established that agents affecting cytoskeleton crystallization
alter as well the RT process and viral infection (Bukrinskaya et al.,
1998). Accordingly, we investigated whether the ability of HIV-1 to
complete RT was affected in sHZ-loaded MDMs compared to
untreated control cells. Results from a sensitive RT-PCR assay that
can detect incomplete and complete reverse transcripts suggested
that this step is not modulated by sHZ. However, when we quantiﬁed
the level of the integrated proviral DNA copies, we found that sHZ-
loaded MDMs contain less proviral DNA inserted within the host
chromosome than in untreated control cells. Therefore, sHZ is most
likely impairing a step taking place between completion of the RT
process and integration of viral genome into the host DNA. Events
occurring between these two different steps include the formation of
viral DNA Flap (Arhel et al., 2006b; Hameau et al., 2001) and a three-
stranded DNA structure acting as a cis-determinant of the HIV-1
genome nuclear import, which promotes uncoating at the nuclear
pore and rapid translocation within the nucleus (Arhel et al., 2007). It
is possible that the stress generated by the engulfment of sHZ renders
MDMsmore refractory to virus infection by promoting degradation ofthe RTC and/or disturbing processes such as uncoating and nuclear
import. It is well recognized that some stressors exert a general
control of the nuclear trafﬁcking by affecting various components of
the transport machinery (Kodiha et al., 2008a). For example, heat
shock and oxidative stress trigger nuclear accumulation of importin-α
in the nuclei of growing cells (Kodiha et al., 2008a; Kodiha et al.,
2008b; Miyamoto et al., 2004). Interestingly, it has been demonstrat-
ed that the HIV-1 RTC is translocated in the nucleus through a
mechanism relying on the viral protein Vpr and the cellular importin-
α in human macrophages (Kamata et al., 2005; Nitahara-Kasahara et
al., 2007; Vodicka et al., 1998). Considering that ingestion of malaria
pigments induces an oxidative stress in macrophages (Schwarzer et
al., 1992; Taramelli et al., 2000), we hypothesized that it could explain
why a treatment of MDMs with sHZ leads to a decrease in HIV-1
integration. Indeed, it is possible that the sHZ-mediated induction of
oxidative stress causes a nuclear import block by anchoring the
importin-α in the nucleus, a phenomenon preventing translocation of
the HIV-1 genome and its subsequent integration in the host DNA
genome. On the other hand, preliminary results have revealed that
sHZ-loaded MDMs contain less intracellular ATP than untreated
control cells (data not shown). Knowing that translocation of the HIV-
1 pre-integration complex to the nucleus is an active transport
process which requires ATP (Bukrinsky et al., 1992; Bukrinsky et al.,
1993) and that HIV-1 integrase was shown to bind ATP (Lipford,
Worland, and Farnet, 1994), it can be postulated that ingestion of
malaria pigments could inhibit HIV-1 infection also via an ATP-
dependent pathway. Furthermore, nuclear accumulation of HIV-1
integrase does not result from passive diffusion but rather from an
active transport that occurs through the nuclear pore complex (NPC)
that may require ATP either to interact with the mediators of its
import or for translocation (Depienne et al., 2001). A more recent
contradictory study also suggests that nuclear import of integrase
appears to be dependent on the importin-α/β heterodimer rather
than ATP (Hearps and Jans, 2006). Thus the sHZ-mediated induction
of oxidative stress could also impair nuclear import of integrase.
Experiments are currently underway to address these scenarios.
Our observations that HIV-1 replication was reduced to the same
extent when using similar concentrations of synthetic (i.e., sHZ) and
native HZ (i.e., PfHZ) provide physiologic signiﬁcance to this work.
The clinical relevance of our results is further supported by the
previous demonstration that, during infection, the amount of HZ
following erythrocyte rupture can reach concentrations as high as
100 μg/ml (Sullivan et al., 1996). Importantly, our ﬁndings weremade
using a maximal concentration of 25 μg/ml of sHZ.
Although data from the most recent clinical and epidemiological
studies suggest that malaria and HIV-1 infections act synergistically to
increase parasite and viral load, we demonstrate here that the
malaria-derived HZ molecule displays a negative impact on HIV-1
replication in a cell type recognized as a major cellular reservoir for
this retrovirus. It seems contradictory that a major constituent of P.
falciparum would reduce virus gene expression when parasite
proteins have been demonstrated to increase viral replication
(Ayouba et al., 2008; Froebel et al., 2004). Our data are also opposite
to that of the Perkins group who found that heme crystals increased
viral load in simian monocytes ﬁrst stimulated with TNF-α (Nti et al.,
2005). The reason(s) for such a discrepancy probably stems from the
fact that P. falciparum and HIV-1 interactions are multifaceted and
complex. This is exempliﬁed by our observations that HIV-1
replication in human primary CD4+ T cells is not affected by sHZ
(data not shown). It can be proposed that HZ exerts a direct effect on
the virus life cycle primarily in cells such as macrophages that can
phagocyte themalaria pigment. However it cannot be totally excluded
that HZ can exert a distinct and more indirect effect in other cell
populations known to harbor HIV-1 by inducing secretion of soluble
factors that can modulate virus gene expression. Additional studies
are warranted to address this issue.
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We demonstrate here that HIV-1 infection of human primary
macrophages is signiﬁcantly reduced by sHZ. This diminution is
associated with a restriction at the level of integration of the HIV-1
genome within host chromosomes. Thus, it can be postulated that
remnant HZ present in the reticuloendothelial cells in patients cured
of malaria diseases or with chronic infection can diminish HIV-1
replication in tissue resident macrophages. Given that HIV-1 can
reside within different cellular reservoirs, additional and more
comprehensive basic studies are needed to fully understand the
consequences of P. falciparum/HIV-1 interactions. This is vital for the
discovery of promising drug combinations and the promotion of new
prevention strategies to treat worldwide co-infected individuals.
Materials and methods
Antibodies
The anti-HIV-1 p24 hybridomas 31-90-25 and 183 H12-5C were
obtained from the American Type Culture Collection (ATCC) (Man-
assas, VA) and the NIH AIDS Repository Reagent Program (German-
town, MD), respectively. Antibodies were puriﬁed by using MAbTrap
protein afﬁnity columns according to the manufacturer's instructions
(Pharmacia Technology AB, Uppsala, Sweden). Alexa Fluor® 488
phalloidin (Molecular Probes, Eugene, OR) is a high-afﬁnity probe for
F-actin. The Vybrant® DiD cell-labeling solution (Molecular Probes) is
a dye delivery solution that can be added directly to normal culture
media to uniformly label suspended or attached cultured cells for use
in cell–cell fusion, cellular adhesion and migration applications. The
rat M1/69 monoclonal antibody reacts with the mouse CD24
molecule (BD Pharmingen, Mississauga, ON), also known as Heat
Stable Antigen (HSA). This antibody was used in conjunction with
Alexa Fluor® 555 goat anti-rat IgG (Molecular Probes).
Cells
Murinemacrophage J774 cells and human embryonic kidney 293 T
cells were obtained from the ATCC and cultured in Dulbecco's
modiﬁed Eagle's medium supplemented with 10% foetal bovine
serum. Peripheral blood mononuclear cells (PBMCs) from healthy
donors were isolated by Ficoll-Hypaque gradient and plated in 75 cm2
ﬂasks (1×107 cells/ml) for 2 h in order to separate by plastic
adherencemonocytes from the other non-adherent cells. After several
washes with endotoxin-free phosphate-buffered saline (PBS) (Sigma-
Aldrich, Oakville, ON), monocytes were cultured in complete RPMI-
1640 medium supplemented with 5% heat-inactivated autologous
serum in the presence of M-CSF (100 ng/ml) for a minimum of 6 days.
Finally, MDMs were recovered with a soft cell scraper following
incubation with Accutase and plated in 48-well plates at a ﬁnal
concentration of 5×104 cells per well in complete RPMI-1640
medium supplemented with 5% autologous serum. Flow cytometry
analyses revealed that the studied MDMs preparations were consti-
tuted mostly of CD14+ cells (i.e., ≥99%) and very few contaminating
CD3+ T cells (i.e., about 0.1%) (data not shown).
Plasmids
The full-length R5-tropic infectious molecular clone of HIV-1
pNL4-3Balenv was generated by replacing the X4-tropic NL4-3 env
gene with that of the Bal strain (kindly provided by R. Pomerantz,
Thomas Jefferson University, Philadelphia, PA) (Dornadula et al.,
1999). The NL4-3Luc+Env−R+ vector produces envelope-deﬁcient
HIV-1 particles coding for the luciferase reporter gene. Single-cycle
reporter viruses were pseudotyped with JR-FL or VSV-G envelope
leading to NL4-3Luc+Env−R+/JR-FL and NL4-3Luc+Env−R+/VSV-Gpseudotypes, respectively. The R5-tropic envelope-encoding JR-FLenv
vector was kindly supplied by N. R. Landau (NYU School of Medicine,
NY), whereas pHCMV-G was obtained from the AIDS Repository
Reagent Program. The latter molecular construct codes for the broad
host-range vesicular stomatitis virus envelope glycoprotein G (VSV-
G) and is placed under the control of the human cytomegalovirus
promoter. The pNLHSA-IRES molecular construct was obtained by
replacing the eGFP gene in the NLENG1-IRES vector (NL4-3 backbone)
(Levy et al., 2004) with the coding sequence for mouse HSA.
Furthermore, the Bal envelope from the pNL4-3Balenv plasmid was
inserted in the pNLHSA-IRES to produce the NL4-3Bal-HSA vector that
can generate fully infectious R5-using virus coding for cell surface HSA
as described recently (Imbeault et al., 2009).
Synthetic HZ preparation
Production of synthetic HZ (sHZ) was achieved using a previously
described methodology with slight modiﬁcations (Jaramillo et al.,
2003). Brieﬂy, 90 mg of hemin chloride (Sigma-Aldrich) was
solubilized in DMSO (crystallization solvent) and added to a 4 M
acetate solution at pH 5.0. The suspension was stirred with a magnet
for 6 h at 65 °C. After adding a volume of 10% SDS, the suspension was
centrifuged at 12,500 × g for 25 min. The pellet was then sonicated
twice at the lowest setting in a solution made of 100 mM sodium
bicarbonate [pH 9.0] and 0.5% SDS and centrifuged again. The pellet
was then washed three times in SDS 2%, at least ﬁve times in sterile
H2O and once in endotoxin-free PBS to eliminate residual SDS. The
ﬁnal pellet was resuspended in endotoxin-free PBS and aliquoted to
obtain a solution of 652 μg/ml sHZ. Natural HZ directly isolated from
P. falciparum cultures (PfHZ) was prepared using an established
technique of serial washes in SDS, protease K digestion, 6 M urea
washes and further SDS and water washes (Noland et al., 2003). The
total heme content of HZwas determined as described by Sullivan and
co-workers (1996). Parasite HZ or crystallized heme was incubated
for 1 h in 2% SDS/20 mM NaOH to solubilize crystal into monomeric
heme, which has a molar extinction coefﬁcient of 1×105 at 400 nm.
Assessment of the biological activity of sHZ
Nitric oxide synthesis was measured by using the murine
macrophage cell line J774. Brieﬂy, cells were seeded in a 48-well
plate (1.25×105 cells/well) and activated for 48 h with the functional
analog of diacylglycerol 12-myristate 13-acetate (PMA) at 20 ng/ml.
Cells were then either left untreated or treated with sHZ (10 μg/ml)
for 24 h and washed with PBS. Next, nitric oxide production was
induced in some samples by a treatment with interferon-γ (IFN-γ)
(100 U/ml). After 48 h, samples were subjected to the Griess reagent
(made of 1% sulfanilamide, 0.1% naphthylethylenediamine dihy-
drochloride and 2.5% H3PO4) to form a chromophore absorbing at
543 nm as described previously (Lorsbach et al., 1993; Stuehr and
Marletta, 1985). Secretion of IL-1β by MDMs was estimated by
treating cells (5×104) with sHZ (10 μg/ml) for 1, 2 and 4 h. Later,
triplicates of each conditions were pooled and a commercial
enzymatic assay (R&D Systems) was used to measure IL-1β protein
levels in undiluted supernatant of MDMs treated or not with sHZ. IL-
1βmeasurements were done on two distinct donors according to the
manufacturer's protocol.
Cell viability assay
MDMs (5×104 cells) were ﬁrst treated with different concentra-
tions of sHZ for 24 h and next incubated or not with NL4-3Balenv for
16 days at 37 °C. Cells were then washed once with PBS and
resuspended in fresh RPMI-1640 medium supplemented with 5%
autologous serum where a MTS solution was added according to the
manufacturer's protocol (ThermoFisher Scientiﬁc, catalogue number
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was measured at 490 nm from the assay plate and was directly
proportional to the number of living cells in culture.
Phagocytosis assay
MDMs (a minimum of 1×105 cells) were ﬁrst either left untreated
or treated with sHZ (10 μg/ml) for 24 h and next recovered with
Accutase as described above. Thereafter, MDMs were resuspended in
opaque FACS tubes in 1ml of fresh RPMI-1640medium supplemented
with opsonized Alexa 488-labeled zymosan particles (Molecular
Probes) in a ratio of 10:1 (zymosan:MDM). Cells were incubated for
0, 5, 15, 30 and 60min at 37 °C and kept on ice for the remaining of the
experiment. Cells were washed and resuspended in endotoxin-free
PBS. To quench non-incorporated zymosan particules, trypan blue
pigments (Merck, Darmstadt, Germany) resuspended in a pH 4.4
citrate solution (0.4 mg/ml) were added and mixed to each sample
before FACS analysis, representing 40% of the ﬁnal concentration used.
Finally, phagocytosis of zymosan particules in MDMs was analysed by
ﬂow cytometry (Epics ELITE ESP; Coulter Electronics).
Virus production
Viruses were produced by the calcium phosphate co-precipitation
method in 293T cells as described previously (Fortin et al., 1997).
Brieﬂy, 293T cells were transfected with pNL4-3Balenv or pNL4-3Bal-
HSA to produce fully infectious R5-tropic HIV-1 particles. In addition,
293T cells were co-transfected with pNL4-3Luc+Env−R+ and pJR-
FLenv or pHCMV-G to obtain pseudotyped HIV-1-based reporter virus.
Virus preparations were normalized for virion content by using an in-
house enzymatic assay speciﬁc for the major viral p24 protein. In this
test, 183 H12-5C and 31-90-25 are used in combination to quantify
p24 levels (Bounou, Leclerc, and Tremblay, 2002). Also, infectivity of
our virus stocks was assessed through the use of TZM-bl indicator
cells. This cell line is a genetically modiﬁed HeLa cell line expressing
large amounts of cell surface CD4, CCR5 and CXCR4 (Steckbeck et al.,
2005). These cells carry separate integrated copies of the luciferase
and β-galactosidase genes under the control of the HIV-1 promoter
and are highly sensitive to infection with different HIV-1 variants
(both R5- and X4-tropic). Virus preparations that did not allow
sufﬁcient reporter gene activity were discarded.
Measurements of HSA-expressing cells, luciferase activity and p24
content
Following infection of MDMs with NL4-3Bal-HSA virus, the
percentage of HSA-expressing cells was estimated by ﬂow cytometry.
In brief, cells were stained either with an isotype-matched irrelevant
control antibody (i.e., IgG1) or M1/69 followed by an Alexa Fluor®
555 goat anti-rat IgG, washed and ﬁxed with paraformaldehyde.
Further on, all cells were resuspended in a solution of PBS and
measurements were made with a ﬂow cytometer. Single stained cells
were also used as controls for compensation adjustments. For MDMs
infected with luciferase-encoding virus, reporter gene activity was
monitored in cell lysates as previously described (Ouellet et al., 2003).
Replication of NL4-3Balenv virus was assessed by quantifying the
accumulation of p24 protein in cell-free supernatant recovered from
infected MDMs and loaded on an ELISA plate to perform our in-house
sensitive double-antibody sandwich p24 test (Bounou, Leclerc, and
Tremblay, 2002).
Live cell microscopy
Images illustrated in Fig. 2 were obtained using time lapse
imaging, performed on aWAVE/FX spinning disk confocal microscope
(Quorum Technologies, Guelph, ON) equipped with a cell cultureincubation chamber, a 60× glycerol objective and using the
appropriate lasers and emission ﬁlters for ﬂuorescent sources or
white light for differential interference contrast. Images were
processed using Volocity Software (Improvision, Waltham, MA).
Brieﬂy, MDMs were plated in eight chamber Lab-Tek™ slides
(1×105 cells per well). Prior to cell culture incubation in the spinning
disk, cells were treated with the DiD cell-labeling solution (1:500
dilution) and left in the chamber for 2 h to stabilized CO2 and
temperature levels. Later, sHZ (10 μg/ml) was added directly onto the
cells. Recording was made during 24 h. Digital images were processed
with ImageJ (version1.36b) and Velocity (version 4.2.1, Improvision).
All the images were taken under similar experimental conditions (i.e.,
exposure time, 60× magniﬁcation and light and laser intensities).
Confocal microscopy
MDMs were seeded on coverslips, exposed to sHZ for 24 h and
infected with NL4-3Bal-HSA virus for 7 days. The cells were then ﬁxed
with 2% paraformaldehyde and permeabilized using 0.1% Triton X-
100. Nonspeciﬁc binding was blocked with 1% bovine serum albumin,
20% goat serum and 10% human serum in PBS. Cells were stained for
actin cytoskeleton with Alexa Fluor 488® phalloidin and virus-
infected cells were revealed with the rat anti-HSA monoclonal
antibody used in combination with Alexa Fluor 555®-conjugated
anti-rat IgG. After several washes, slides were mounted in SlowFade
medium (Molecular Probes, Eugene, OR). Stained cells were visual-
ized by confocal laser scanning microscopy (Fluoview FV300;
Olympus, Melville, NY). Digital images were processed with Velocity
(version 4.2.1, Improvision). All the images were taken under similar
experimental conditions (i.e., exposure time, 60× magniﬁcation and
light and laser intensities).
Kinetics of HIV-1 infection
MDMs were infected with a ﬁxed amount of virus (i.e., 5 ng of p24
per 5×104 cells). In the case of infection with HIV-1 pseudotypes,
viruses were left in the medium throughout the experiment while
during infection with fully competent HIV-1 particles, half of the
supernatant was collected and fresh mediumwas added every 3 days.
In most studies, cells were treated with different concentrations of
sHZ at 24 h before infection. Concerning the post-infection assay,
MDMs were ﬁrst infected with HIV-1 and then treated with sHZ at 0,
4, 24, 48 or 72 h post-infection.
Virus entry assay
MDMs (5×104 cells) were ﬁrst treated with different concentra-
tions of sHZ for 24 h and next incubated either with NL4-3Balenv or
NL4-3Luc+Env−R+/JR-FL pseudotypes (5 ng of p24) for 60 min at
37 °C. Cells were then washed once with PBS, treated with trypsin for
5 min at 37 °C to remove all uninternalized virions, washed three
times and then immediately lysed in ice-cold lysis buffer (20 mM
HEPES [pH 7.4], 150 mM sodium chloride and 0.5% Triton X 100).
Finally, the p24 contents were evaluated by ELISA.
Real-time PCR
For detection and quantiﬁcation of different forms of reverse
transcripts (i.e., initiated and completed) and integrated viral DNA
copies, genomic DNA from a total of 1×106 MDMs either left
unexposed or treated for 24 h with Hz (10 μg/ml) and infected for
up to 48 h with NL4-3Balenv was extracted using the DNeasy Blood
and Tissue Kit from QIAGEN (Mississauga, ON). Quantiﬁcation of HIV-
1 reverse transcripts was achieved by subjecting 25 ng of DNA to a
real-time PCR test in a 25 μl reaction containing 2× TaqMan Universal
PCR Master Mix (Applied Biosystems, Foster City, CA), 1 μM of the
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antisense primer M661 and 0.3 μM of the TaqMan probe HIV-5′-
carboxyﬂuorescein (Biosearch Technologies, Novato, CA) (Zack et al.,
1990). HIV-1 standards consisted of 25 ng of DNA from uninfected
cells. For monitoring integrated viral DNA copies, DNA was quantiﬁed
and subjected to a combined Alu-HIV-1 PCR and real-time PCR as
described by Suzuki and co-workers (2003). Brieﬂy, genomic DNA
(100 ng) from MDMs either left untreated or treated with sHZ (5 and
10 μg/ml) and infected for 48 hwith HIV-1was ﬁrst ampliﬁedwith an
Alu-sequence-speciﬁc sense primer (Chun et al., 1997) and HIV-1-
speciﬁc antisense primer (i.e., M661). Next, 5 μl of 25-fold diluted PCR
products were subjected to a real-time PCR assay in a 25 μl reaction
containing 2× TaqMan Universal PCR Master Mix (Applied Biosys-
tems), 2 μMof the HIV-1-speciﬁc sense primerM667, 2 μMof the HIV-
1-speciﬁc antisense primer AA55 and 0.3 μM of the TaqMan probe
HIV-5′-carboxyﬂuorescein (Biosearch Technologies) (Suzuki et al.,
2003). The cycling conditions used for the Applied Biosystems 7500
sequence detection system included a hot start (50 °C for 2 min and
95 °C for 10 min), followed by 40 cycles of denaturation (95 °C for
1 min) and extension (63 °C for 1 min) with end point acquisition.
NL4-3Balenv DNA was used for the standard curve (i.e., from 469 to
30,000 copies). All HIV-1 standards contained 1 ng of DNA from
uninfected cells as carrier.
Statistical analysis
Results presented are expressed as means±standard error of the
mean (SEM) of triplicate samples. All of the experiments were
repeated at least two times and each ﬁgure combines the results
obtained with all the different donors. Because there might be some
donor-to-donor variations, most ﬁgures are expressed as percentages
of inhibition calculated with Prism version 3.03. Statistical signiﬁ-
cance between groups was determined by analysis of variance.
Calculations were made with Prism version 3.03. P values b0.05 were
considered statistically signiﬁcant. The statistical signiﬁcance of the
results was deﬁned by performing a one-way analysis of variancewith
Dunnett's post tests to compare treated and untreated control
samples. In some cases, t test analyses were made on raw data.
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